SERB SA secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient amifampridine, ATC N07XX05 for the period 01092025 - 31082027 (plus extension option 1x12 months)

Posted On: 2026-07-09

Germany, July 9 -- Germany based SERB SA has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient amifampridine, ATC N07XX05 for the period 01092025 - 31082027 (plus extension option 1x12 months) . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

SERB SA secures contract for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient amifampridine, ATC N07XX05 for the period 01092025 - 31082027 (plus extension option 1x12 months)